Do I Need a Membership for a Diabetes Prescription?

Most people who wonder whether to pay a membership for a diabetes prescription already know which medication they want. They have read about it, a friend takes it, or a pharmacist mentioned it. What they are really asking is whether anything besides the prescription is worth a monthly fee.

This piece answers that question for one reader: an adult who has lived with type 2 diabetes for more than a decade, pays around $600 a month for health insurance, and is still not well managed. For that reader the answer turns on one thing. If you want a clinician to lay out the whole metabolic picture and then keep watching it, a membership can make sense. If you want a script and nothing more, GoodLife Health is the wrong purchase, and the section near the end called "Who this is not for" says so plainly.

GoodLife Health is a clinician-led membership for cardiometabolic care. It costs $299 a month, medication is billed separately by the pharmacy you choose, and not everyone who applies is accepted. Everything below is written so that you can decide before you reach the checkout.

Ten years of refills, and nobody has walked you through the numbers

If you were diagnosed more than ten years ago, you probably know the routine by heart. Each visit brings a blood draw, an HbA1c that is a little better or a little worse than last time, a refill, and sometimes a second medication or a higher dose. Then comes the next visit, months later, and the same conversation in a shorter form.

Very little of that is anyone's fault. The Learning Center's guide to what a direct primary care membership includes notes that a traditional primary care appointment averages 18 minutes, and that clinicians in fee-for-service practices see 20–25 patients a day to cover overhead. In 18 minutes a clinician can review a number, renew a medication and answer a question or two. Explaining how your glucose, your cholesterol, your liver and your weight relate to one another, in your body, across a decade, does not fit in that time.

So you have learned, reasonably, that the visit exists to produce the prescription. The prescription is the part that seemed to do something. When you read about newer medications, the obvious move is to find the fastest route to getting one written and to skip the part of care that has never felt useful.

Meanwhile you pay around $600 a month for insurance. That premium is what stands between you and the cost of a hospital stay or an emergency, and nothing in this piece suggests dropping it. The frustration is that you pay it and still feel that nobody has looked at the whole picture. The real question underneath yours is why you should pay more for a kind of care that has not worked so far.

Still not well managed after a decade is a specific situation. It means the treatment has probably been adjusted, perhaps several times, and the numbers have kept drifting anyway. That deserves a closer look before you decide what to buy.

What a prescription can tell you, and what it cannot

A prescription is a decision made on one day; whether it is working is a question you answer over months, in your own lab results. That second part is where long-term diabetes care tends to thin out, and it is the part a membership is built around.

Before a GLP-1 medication is started, the standard metabolic labs include fasting glucose, HbA1c, a lipid panel and liver enzymes. Those numbers show where you begin. Repeated on a schedule, they show whether the dose is doing what it should, whether something else has moved, and whether the plan needs to change. A dose raised without that information is a guess, and so is a medication switched without it. When treatment has changed several times and the numbers still drift, the useful step is to measure often enough to see a trend and to have someone read the trend with you.

Explaining the whole picture means putting those numbers side by side and telling you what they mean for you: which ones have moved, which ones have held, and what the plan is meant to change before the next panel. With every result in your own hands, you can see what the clinician sees and ask about it.

There is a second thing going on, and it concerns how the cheap route to a prescription gets paid for. The Learning Center's white paper on how GLP-1 telehealth companies make money sorts every company into three models. In the first, the company earns a margin on the medication, so the membership fee looks small and the medicine costs more than it would at a pharmacy. In the second, a low membership fee is paired with billing your insurance. In the third, one flat fee covers the care and the medicine is sold at the pharmacy's own price. As the paper puts it, the way a company gets paid is the pressure its clinicians work under. The paper is careful to judge no company by its model; the model decides what a company is rewarded for.

This matters to anyone who only wants the prescription, because the low price on a homepage does not always hold once the medicine is added. The comparison chart behind that white paper, compiled from public pricing pages in May 2026, found branded Zepbound or Mounjaro offered at up to $1,899 a month through some telehealth memberships. As published in September 2026, LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. A prescription that looks free can carry its cost inside the price of the medicine.

The cheapest route of all used to be compounded GLP-1: pharmacy-made copies of semaglutide and tirzepatide, often sold with a low monthly fee. Those copies were legal while the medicines were on the FDA's shortage list, and people who used them did nothing wrong. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved on February 21, 2025, and the last enforcement grace periods closed in spring 2025. The agency sets out its position on its page about unapproved GLP-1 drugs used for weight loss, and both manufacturers have sued companies selling compounded versions. What remains is a narrow exception for a specific patient with a documented need the branded product cannot meet. GoodLife Health does not prescribe compounded GLP-1. That choice means members pay the branded price, which is higher, and it is one reason a $99-a-month app and this membership are different purchases.

What the $299 pays for, and what it does not

The membership is $299 a month, month to month. At sign-up, $598 is charged, which covers the first two months, and over a year the membership comes to $3,588. The fee is generally eligible for HSA or FSA pre-tax dollars.

For that fee you get clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your own hands, asynchronous messaging with the care team, and video visits. The quarterly labs answer the question a single prescription leaves open. Each panel shows whether the plan is working, and each result comes to you, so the picture builds up in front of you over the year. Between panels, messaging means a question about a side effect or a reading can go to the care team without waiting for the next visit.

The fee is the same whatever medication is indicated and whatever the dose, with no molecule upcharge and no dose upcharge. GoodLife Health calls this Medication-Neutral Pricing. Nobody at the company earns more because you are on a stronger medication, a higher dose, or any medication at all.

Medication is unbundled. When a clinician judges a medication clinically indicated, it is prescribed to the pharmacy you choose, at that pharmacy's own price, and GoodLife Health sets nothing, sees nothing and takes nothing on it. Prescriptions are branded and FDA-approved. For GLP-1 that means Wegovy, Zepbound, Mounjaro or Ozempic, and any FDA-approved medication a clinician judges indicated can be sent to your pharmacy. Semaglutide is sold as Ozempic for diabetes and Wegovy for weight; tirzepatide is sold as Mounjaro for diabetes and Zepbound for weight. The manufacturers' own self-pay prices, as published in September 2026, cover the weight brands. Through NovoCare, Wegovy pens were $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after, and the Wegovy pill started at $149 a month at lower doses. Through LillyDirect, Zepbound vials were $299 to $449 a month depending on dose. This piece has no published self-pay price to quote for Ozempic or Mounjaro, and which medication fits you is the clinician's decision.

You keep your insurance. The membership pairs with it for catastrophic coverage and does not replace it; what it replaces is the primary-care relationship. Whether your plan covers a given medication is between you, your plan and the pharmacy, and it is never promised here. Prior authorization is the pharmacy's process, and GoodLife Health does not run it, speed it up or promise how it turns out.

Not everyone is accepted. The path is the eligibility check, the intake, the checkout and then a clinician's review. If the clinician cannot accept you into care, the $598 is refunded in full. Once you are accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

The membership does not promise a result. GoodLife Health does not promise a particular HbA1c, any amount of weight loss, remission or a cure. Continuous glucose monitors are not part of the model, which matters if you were hoping to have one supplied and managed through the membership.

The honest answer to your question

You asked why you would pay a membership when you just want the prescription. If the prescription really is all you want, you should not pay for this one. The fee buys the part of care that comes after the prescription: labs every quarter, results in your hands, and a clinician who reads them with you and changes the plan when the numbers call for it. If you would skip the labs and leave the messages unread, you would be paying $299 a month for a prescription that other routes may provide for less.

If, after more than a decade, what you want is for someone to explain how your numbers fit together and then keep watching them, the question changes. What you would be paying for is the follow-up that shows whether a prescription is the right one, at the right dose, for you.

Weigh that against what you already spend. A membership on top of an insurance premium is real money. The eligibility check exists so that you can find out whether you are a fit before the checkout. If a clinician then cannot accept you, the $598 comes back in full; once you are accepted, the first two months are non-refundable.

Who this is not for

This section is here so that the wrong buyer leaves before the checkout. If one of these describes you, a GoodLife Health membership is probably the wrong choice, and it is better to know now.

You want a prescription and nothing else. If you will not do quarterly labs, read your results or answer a message from the care team, the fee pays for a relationship you do not intend to use.

Your current care already works. If your clinician will prescribe what you need, your plan covers it, and someone is watching your numbers between visits, keep that arrangement. A membership would add cost without adding much.

You are shopping for the lowest monthly number. A $99-a-month app is a different purchase. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and it says so. It prescribes branded, FDA-approved medication only, so your medication costs what your pharmacy charges for the branded product.

You want a guarantee. The membership does not promise a specific medication, insurance coverage, a successful prior authorization, a target HbA1c, weight loss, remission or a cure. The clinician decides what is indicated.

You hope to drop your insurance. The membership does not replace insurance. Keep your plan for the hospital stays, emergencies and specialist care it exists to cover.

You want a continuous glucose monitor run through the membership. Monitors are not part of the model.

You need care in a room. Care happens through video visits and asynchronous messaging, and there are no in-office procedures. If you need someone to examine you in person, a local practice is the better fit.

The fee would strain your budget. If adding $299 a month to the premium you already pay would mean skipping a pharmacy bill, do not sign up. Paying for the medication you already take comes first.

If none of these describes you, and seeing your whole metabolic picture laid out every quarter sounds like the thing that has been missing for ten years, the eligibility check is the next step. A clinician still makes the final call.

Related Reading

• How GLP-1 Telehealth Companies Make Money: A Plain-Language Whitepaper
• What Does Direct Primary Care Include in 2026

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss